AU2002352123A1 - N-ureido-piperidines as antagonists viii for ccr-3 receptor - Google Patents
N-ureido-piperidines as antagonists viii for ccr-3 receptor Download PDFInfo
- Publication number
- AU2002352123A1 AU2002352123A1 AU2002352123A AU2002352123A AU2002352123A1 AU 2002352123 A1 AU2002352123 A1 AU 2002352123A1 AU 2002352123 A AU2002352123 A AU 2002352123A AU 2002352123 A AU2002352123 A AU 2002352123A AU 2002352123 A1 AU2002352123 A1 AU 2002352123A1
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- chlorobenzyl
- piperidin
- trans
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004499 CCR3 Receptors Human genes 0.000 title claims description 13
- 108010017316 CCR3 Receptors Proteins 0.000 title claims description 13
- 239000005557 antagonist Substances 0.000 title description 3
- SKJJGBRWKOFYAD-UHFFFAOYSA-N piperidin-1-ylurea Chemical class NC(=O)NN1CCCCC1 SKJJGBRWKOFYAD-UHFFFAOYSA-N 0.000 title 1
- -1 2,5-difluorophenyl Chemical group 0.000 claims description 296
- 150000001875 compounds Chemical class 0.000 claims description 199
- 125000000217 alkyl group Chemical group 0.000 claims description 90
- 238000000034 method Methods 0.000 claims description 84
- 229910052739 hydrogen Inorganic materials 0.000 claims description 72
- 239000000203 mixture Substances 0.000 claims description 56
- 239000001257 hydrogen Substances 0.000 claims description 50
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 42
- 229920006395 saturated elastomer Polymers 0.000 claims description 32
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 29
- 150000002431 hydrogen Chemical class 0.000 claims description 26
- 125000003282 alkyl amino group Chemical group 0.000 claims description 23
- 229910052799 carbon Inorganic materials 0.000 claims description 23
- 125000003118 aryl group Chemical group 0.000 claims description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 22
- 201000010099 disease Diseases 0.000 claims description 21
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 20
- 125000002252 acyl group Chemical group 0.000 claims description 19
- 125000003545 alkoxy group Chemical group 0.000 claims description 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 17
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 16
- 125000000623 heterocyclic group Chemical group 0.000 claims description 15
- 150000003254 radicals Chemical class 0.000 claims description 14
- 125000001424 substituent group Chemical group 0.000 claims description 14
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims description 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- 239000012948 isocyanate Substances 0.000 claims description 12
- 150000002513 isocyanates Chemical class 0.000 claims description 12
- 125000006413 ring segment Chemical group 0.000 claims description 12
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 11
- 208000006673 asthma Diseases 0.000 claims description 10
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 10
- 125000004442 acylamino group Chemical group 0.000 claims description 9
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 9
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims description 8
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 8
- 229940002612 prodrug Drugs 0.000 claims description 8
- 239000000651 prodrug Substances 0.000 claims description 8
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 7
- 229910020008 S(O) Inorganic materials 0.000 claims description 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 7
- 125000004414 alkyl thio group Chemical group 0.000 claims description 7
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 7
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 6
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims description 6
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 5
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims description 4
- 125000005842 heteroatom Chemical group 0.000 claims description 4
- 239000000543 intermediate Substances 0.000 claims description 4
- 125000002950 monocyclic group Chemical group 0.000 claims description 4
- 239000002464 receptor antagonist Substances 0.000 claims description 4
- 229940044551 receptor antagonist Drugs 0.000 claims description 4
- OMIVCRYZSXDGAB-UHFFFAOYSA-N 1,4-butanediyl Chemical group [CH2]CC[CH2] OMIVCRYZSXDGAB-UHFFFAOYSA-N 0.000 claims description 3
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims description 3
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims description 3
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims description 3
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims description 3
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 3
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims description 3
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims description 3
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 3
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 3
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 3
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims description 3
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 3
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 claims description 3
- 125000004861 4-isopropyl phenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 3
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 3
- 125000002249 indol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([*])=C([H])C2=C1[H] 0.000 claims description 3
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 3
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 3
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims description 3
- CUJPFPXNDSIBPG-UHFFFAOYSA-N 1,3-propanediyl Chemical group [CH2]C[CH2] CUJPFPXNDSIBPG-UHFFFAOYSA-N 0.000 claims description 2
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 238000003745 diagnosis Methods 0.000 claims description 2
- 238000013160 medical therapy Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 125000001475 halogen functional group Chemical group 0.000 claims 14
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 8
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 8
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 2
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 2
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 claims 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 292
- 239000000243 solution Substances 0.000 description 99
- 238000002360 preparation method Methods 0.000 description 85
- 239000000047 product Substances 0.000 description 82
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 78
- 239000007787 solid Substances 0.000 description 75
- 238000005481 NMR spectroscopy Methods 0.000 description 51
- 239000012458 free base Substances 0.000 description 48
- 238000004587 chromatography analysis Methods 0.000 description 43
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 39
- 235000019439 ethyl acetate Nutrition 0.000 description 39
- 239000000284 extract Substances 0.000 description 39
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 38
- 238000012746 preparative thin layer chromatography Methods 0.000 description 37
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 36
- 239000008346 aqueous phase Substances 0.000 description 35
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 33
- 238000000746 purification Methods 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 32
- 150000001412 amines Chemical class 0.000 description 28
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 27
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 25
- 239000012043 crude product Substances 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 23
- 230000015572 biosynthetic process Effects 0.000 description 22
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 21
- 101710139422 Eotaxin Proteins 0.000 description 21
- 102100023688 Eotaxin Human genes 0.000 description 21
- 229910052757 nitrogen Inorganic materials 0.000 description 21
- 238000003786 synthesis reaction Methods 0.000 description 20
- 210000003979 eosinophil Anatomy 0.000 description 19
- VPESQEWIPDEGSY-UHFFFAOYSA-N 4-[(4-chlorophenyl)methyl]piperidine Chemical compound C1=CC(Cl)=CC=C1CC1CCNCC1 VPESQEWIPDEGSY-UHFFFAOYSA-N 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 18
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 16
- 239000012267 brine Substances 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 15
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 14
- 125000004663 dialkyl amino group Chemical group 0.000 description 14
- 235000013877 carbamide Nutrition 0.000 description 13
- 238000005160 1H NMR spectroscopy Methods 0.000 description 12
- MJJXWPHZDBIHIM-UHFFFAOYSA-N 5-isocyanato-1,2,3-trimethoxybenzene Chemical compound COC1=CC(N=C=O)=CC(OC)=C1OC MJJXWPHZDBIHIM-UHFFFAOYSA-N 0.000 description 12
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 description 12
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- 239000004202 carbamide Substances 0.000 description 12
- 238000001914 filtration Methods 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 10
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 10
- 125000001188 haloalkyl group Chemical group 0.000 description 10
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 239000008194 pharmaceutical composition Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 229910017974 NH40H Inorganic materials 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- 230000035605 chemotaxis Effects 0.000 description 9
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 9
- SZSVDCAYAJSULK-FGZHOGPDSA-N 1-[(3r,4r)-4-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]pyrrolidin-3-yl]-3-(3,4,5-trimethoxyphenyl)urea Chemical compound COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](CNC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 SZSVDCAYAJSULK-FGZHOGPDSA-N 0.000 description 8
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 8
- 102100032367 C-C motif chemokine 5 Human genes 0.000 description 8
- 102100032366 C-C motif chemokine 7 Human genes 0.000 description 8
- 101710155834 C-C motif chemokine 7 Proteins 0.000 description 8
- 239000004215 Carbon black (E152) Substances 0.000 description 8
- 108010055166 Chemokine CCL5 Proteins 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 8
- 239000012230 colorless oil Substances 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 125000005843 halogen group Chemical group 0.000 description 8
- 229930195733 hydrocarbon Natural products 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-diisopropylethylamine Substances CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 239000006260 foam Substances 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 108010058846 Ovalbumin Proteins 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 6
- 239000002502 liposome Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 229940092253 ovalbumin Drugs 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000443 aerosol Substances 0.000 description 5
- 125000003710 aryl alkyl group Chemical group 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 125000003884 phenylalkyl group Chemical group 0.000 description 5
- 125000006239 protecting group Chemical group 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 5
- 150000003672 ureas Chemical class 0.000 description 5
- GQACHRPIDDZDMB-QZTJIDSGSA-N (1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclohexan-1-amine Chemical compound N[C@@H]1CCCC[C@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 GQACHRPIDDZDMB-QZTJIDSGSA-N 0.000 description 4
- AJBWNNKDUMXZLM-UHFFFAOYSA-N 4-methylsulfonylbenzoic acid Chemical compound CS(=O)(=O)C1=CC=C(C(O)=O)C=C1 AJBWNNKDUMXZLM-UHFFFAOYSA-N 0.000 description 4
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 125000001309 chloro group Chemical group Cl* 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- KZZKOVLJUKWSKX-UHFFFAOYSA-N cyclobutanamine Chemical class NC1CCC1 KZZKOVLJUKWSKX-UHFFFAOYSA-N 0.000 description 4
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 125000001207 fluorophenyl group Chemical group 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- GQACHRPIDDZDMB-MSOLQXFVSA-N (1r,2s)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclohexan-1-amine Chemical compound N[C@@H]1CCCC[C@@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 GQACHRPIDDZDMB-MSOLQXFVSA-N 0.000 description 3
- IJLUGKBVJWIXED-TUACAJSNSA-N 1-[(1r,2r,4s)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]-4-(hydroxymethyl)cyclopentyl]-3-(3,4,5-trimethoxyphenyl)urea Chemical compound COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](C[C@@H](CO)C2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 IJLUGKBVJWIXED-TUACAJSNSA-N 0.000 description 3
- HFELMIUVFLEMLD-YTFSRNRJSA-N 1-[(1r,2r,4s)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]-4-hydroxycyclopentyl]-3-(3,4,5-trimethoxyphenyl)urea Chemical compound COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](C[C@@H](O)C2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 HFELMIUVFLEMLD-YTFSRNRJSA-N 0.000 description 3
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 3
- ILTLDWFMIIDPAO-UHFFFAOYSA-N 2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]-n-methoxycyclobutan-1-imine Chemical compound CON=C1CCC1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 ILTLDWFMIIDPAO-UHFFFAOYSA-N 0.000 description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- 108010012236 Chemokines Proteins 0.000 description 3
- 102000019034 Chemokines Human genes 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ONMROWMJXRYBAN-VXGBXAGGSA-N [(1r,2r)-2-azidocyclohexyl] 4-nitrobenzenesulfonate Chemical compound C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)O[C@H]1[C@H](N=[N+]=[N-])CCCC1 ONMROWMJXRYBAN-VXGBXAGGSA-N 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000003042 antagnostic effect Effects 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 125000001246 bromo group Chemical group Br* 0.000 description 3
- 244000309464 bull Species 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000003862 glucocorticoid Substances 0.000 description 3
- 125000004438 haloalkoxy group Chemical group 0.000 description 3
- 238000000099 in vitro assay Methods 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000006199 nebulizer Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229940124531 pharmaceutical excipient Drugs 0.000 description 3
- ATROHALUCMTWTB-OWBHPGMISA-N phoxim Chemical compound CCOP(=S)(OCC)O\N=C(\C#N)C1=CC=CC=C1 ATROHALUCMTWTB-OWBHPGMISA-N 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 150000003235 pyrrolidines Chemical class 0.000 description 3
- 230000007115 recruitment Effects 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229940037128 systemic glucocorticoids Drugs 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 125000001544 thienyl group Chemical group 0.000 description 3
- NONOKGVFTBWRLD-UHFFFAOYSA-N thioisocyanate group Chemical group S(N=C=O)N=C=O NONOKGVFTBWRLD-UHFFFAOYSA-N 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 229960000281 trometamol Drugs 0.000 description 3
- OPELPXDOYUZMHI-HZPDHXFCSA-N (1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclobutan-1-amine Chemical compound N[C@@H]1CC[C@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 OPELPXDOYUZMHI-HZPDHXFCSA-N 0.000 description 2
- PYNGHJRZUVXEJW-IAGOWNOFSA-N (1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentan-1-amine Chemical compound N[C@@H]1CCC[C@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 PYNGHJRZUVXEJW-IAGOWNOFSA-N 0.000 description 2
- OPELPXDOYUZMHI-CVEARBPZSA-N (1r,2s)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclobutan-1-amine Chemical compound N[C@@H]1CC[C@@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 OPELPXDOYUZMHI-CVEARBPZSA-N 0.000 description 2
- PYNGHJRZUVXEJW-SJORKVTESA-N (1r,2s)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentan-1-amine Chemical compound N[C@@H]1CCC[C@@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 PYNGHJRZUVXEJW-SJORKVTESA-N 0.000 description 2
- BGKXORBNYPNIKB-HZPDHXFCSA-N (3s,4r)-4-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]oxolan-3-ol Chemical compound O[C@@H]1COC[C@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 BGKXORBNYPNIKB-HZPDHXFCSA-N 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 2
- LLZFABYEXPSZCJ-JWQCQUIFSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-quinolin-2-ylurea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC=2N=C3C=CC=CC3=CC=2)CC1 LLZFABYEXPSZCJ-JWQCQUIFSA-N 0.000 description 2
- WSEKJKPOESBXTN-ZWKOTPCHSA-N 1-[(1r,2s)-2-azidocyclohexyl]-4-[(4-chlorophenyl)methyl]piperidine Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@H](CCCC2)N=[N+]=[N-])CC1 WSEKJKPOESBXTN-ZWKOTPCHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- WTBBTMBWFGTEIR-UHFFFAOYSA-N 2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclobutan-1-one Chemical compound C1=CC(Cl)=CC=C1CC1CCN(C2C(CC2)=O)CC1 WTBBTMBWFGTEIR-UHFFFAOYSA-N 0.000 description 2
- PYNGHJRZUVXEJW-UHFFFAOYSA-N 2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentan-1-amine Chemical compound NC1CCCC1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 PYNGHJRZUVXEJW-UHFFFAOYSA-N 0.000 description 2
- IEEHKTFVUIVORU-UHFFFAOYSA-N 2-methylpropanedioyl dichloride Chemical compound ClC(=O)C(C)C(Cl)=O IEEHKTFVUIVORU-UHFFFAOYSA-N 0.000 description 2
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- JXRGUPLJCCDGKG-UHFFFAOYSA-N 4-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=C(S(Cl)(=O)=O)C=C1 JXRGUPLJCCDGKG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 2
- UHBGYFCCKRAEHA-UHFFFAOYSA-N P-toluamide Chemical compound CC1=CC=C(C(N)=O)C=C1 UHBGYFCCKRAEHA-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 229910018557 Si O Inorganic materials 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 238000010640 amide synthesis reaction Methods 0.000 description 2
- 150000001414 amino alcohols Chemical class 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- 239000012131 assay buffer Substances 0.000 description 2
- 239000012911 assay medium Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 2
- 125000005243 carbonyl alkyl group Chemical group 0.000 description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 125000000068 chlorophenyl group Chemical group 0.000 description 2
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940088679 drug related substance Drugs 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 150000002118 epoxides Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000007972 injectable composition Substances 0.000 description 2
- 125000002346 iodo group Chemical group I* 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000005956 isoquinolyl group Chemical group 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- RHCSKNNOAZULRK-UHFFFAOYSA-N mescaline Chemical compound COC1=CC(CCN)=CC(OC)=C1OC RHCSKNNOAZULRK-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical group OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 150000003053 piperidines Chemical class 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
- 125000005493 quinolyl group Chemical group 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 229960002317 succinimide Drugs 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- BLXLRKHYFFPWCB-RTBURBONSA-N tert-butyl (3r,4r)-3-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]-4-hydroxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)C[C@@H](O)[C@@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 BLXLRKHYFFPWCB-RTBURBONSA-N 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- 125000003507 tetrahydrothiofenyl group Chemical group 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- WOBRFSDEZREQAB-UHFFFAOYSA-N trimethyl-(2-trimethylsilyloxycyclobuten-1-yl)oxysilane Chemical compound C[Si](C)(C)OC1=C(O[Si](C)(C)C)CC1 WOBRFSDEZREQAB-UHFFFAOYSA-N 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- YYEVSKCOCGPTQP-QZTJIDSGSA-N (1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclohexan-1-ol Chemical compound O[C@@H]1CCCC[C@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 YYEVSKCOCGPTQP-QZTJIDSGSA-N 0.000 description 1
- CHYODESHQQQYFD-IAGOWNOFSA-N (1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentan-1-ol Chemical compound O[C@@H]1CCC[C@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 CHYODESHQQQYFD-IAGOWNOFSA-N 0.000 description 1
- QECSGTHYJAPXMH-PHDIDXHHSA-N (1r,2r)-2-azidocyclohexan-1-ol Chemical compound O[C@@H]1CCCC[C@H]1N=[N+]=[N-] QECSGTHYJAPXMH-PHDIDXHHSA-N 0.000 description 1
- HUHPZGBAWPMUCZ-RFZPGFLSSA-N (1r,2r)-2-azidocyclopentan-1-ol Chemical compound O[C@@H]1CCC[C@H]1N=[N+]=[N-] HUHPZGBAWPMUCZ-RFZPGFLSSA-N 0.000 description 1
- HKSOUZZVSMMVDH-YMPZKCBVSA-N (1r,2r,4r)-4-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentan-1-ol Chemical compound C1[C@@H](CO[Si](C)(C)C(C)(C)C)C[C@@H](O)[C@@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 HKSOUZZVSMMVDH-YMPZKCBVSA-N 0.000 description 1
- SWYURTPWLRXHSW-YPAWHYETSA-N (1r,2r,4r)-4-[tert-butyl(dimethyl)silyl]oxy-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentan-1-ol Chemical compound C1[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H](O)[C@@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 SWYURTPWLRXHSW-YPAWHYETSA-N 0.000 description 1
- FYXLHHRTVBDDNF-MDNUFGMLSA-N (1r,2r,4s)-4-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentan-1-amine Chemical compound C1[C@@H](CO[Si](C)(C)C(C)(C)C)C[C@@H](N)[C@@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 FYXLHHRTVBDDNF-MDNUFGMLSA-N 0.000 description 1
- XRRRAGZCAVAWEE-UHFFFAOYSA-N (2-methylphenyl)methylurea Chemical compound CC1=CC=CC=C1CNC(N)=O XRRRAGZCAVAWEE-UHFFFAOYSA-N 0.000 description 1
- YGWYHKKVQPPMIW-UHFFFAOYSA-N (2-methylquinolin-6-yl)urea Chemical compound C1=C(NC(N)=O)C=CC2=NC(C)=CC=C21 YGWYHKKVQPPMIW-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- QOQYLBCFHCBREM-UHFFFAOYSA-N (3,4,5-trimethoxyphenyl)urea Chemical compound COC1=CC(NC(N)=O)=CC(OC)=C1OC QOQYLBCFHCBREM-UHFFFAOYSA-N 0.000 description 1
- JTBHRQOVNMWOJV-UHFFFAOYSA-N (3,4,5-trimethoxyphenyl)urea hydrochloride Chemical compound Cl.COC1=CC(NC(N)=O)=CC(OC)=C1OC JTBHRQOVNMWOJV-UHFFFAOYSA-N 0.000 description 1
- SUJUZMVBSUBMJC-DNQXCXABSA-N (3,4-dichlorophenyl)methyl n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]carbamate Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)OCC=2C=C(Cl)C(Cl)=CC=2)CC1 SUJUZMVBSUBMJC-DNQXCXABSA-N 0.000 description 1
- KPUATPHOGDRICS-DNQXCXABSA-N (3,5-dichlorophenyl)methyl n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]carbamate Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)OCC=2C=C(Cl)C=C(Cl)C=2)CC1 KPUATPHOGDRICS-DNQXCXABSA-N 0.000 description 1
- WLRTWKLFJILMSU-UHFFFAOYSA-N (3-chloro-2-methylphenyl)urea Chemical compound CC1=C(Cl)C=CC=C1NC(N)=O WLRTWKLFJILMSU-UHFFFAOYSA-N 0.000 description 1
- PZFIPZDQMSKUDS-DNQXCXABSA-N (3-chlorophenyl)methyl n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]carbamate Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)OCC=2C=C(Cl)C=CC=2)CC1 PZFIPZDQMSKUDS-DNQXCXABSA-N 0.000 description 1
- OARQYBFTOIZAPA-UHFFFAOYSA-N (3-methylphenyl)methylurea Chemical compound CC1=CC=CC(CNC(N)=O)=C1 OARQYBFTOIZAPA-UHFFFAOYSA-N 0.000 description 1
- VKBRQQLOUXHSTD-DNQXCXABSA-N (3-nitrophenyl)methyl n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]carbamate Chemical compound [O-][N+](=O)C1=CC=CC(COC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 VKBRQQLOUXHSTD-DNQXCXABSA-N 0.000 description 1
- WPUJTNVLTZSMMA-HZPDHXFCSA-N (3s,4s)-4-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]oxolan-3-amine Chemical compound N[C@@H]1COC[C@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 WPUJTNVLTZSMMA-HZPDHXFCSA-N 0.000 description 1
- ZRMCGIWXRFPNMC-UHFFFAOYSA-N (4-chloro-3-nitrophenyl)urea Chemical compound NC(=O)NC1=CC=C(Cl)C([N+]([O-])=O)=C1 ZRMCGIWXRFPNMC-UHFFFAOYSA-N 0.000 description 1
- YLFRZTMXDWOXIO-UHFFFAOYSA-N (4-cyanophenyl)urea Chemical compound NC(=O)NC1=CC=C(C#N)C=C1 YLFRZTMXDWOXIO-UHFFFAOYSA-N 0.000 description 1
- PCKCTBMQZSHNNS-UHFFFAOYSA-N (4-ethylphenyl)urea Chemical compound CCC1=CC=C(NC(N)=O)C=C1 PCKCTBMQZSHNNS-UHFFFAOYSA-N 0.000 description 1
- IWNMDGNZYOLNSD-DNQXCXABSA-N (4-fluorophenyl)methyl n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]carbamate Chemical compound C1=CC(F)=CC=C1COC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 IWNMDGNZYOLNSD-DNQXCXABSA-N 0.000 description 1
- ISIFPVOJHJASJW-UHFFFAOYSA-N (4-fluorophenyl)methylurea Chemical compound NC(=O)NCC1=CC=C(F)C=C1 ISIFPVOJHJASJW-UHFFFAOYSA-N 0.000 description 1
- CWQOSUOSPHUYTM-UHFFFAOYSA-N (4-methylphenyl)methylurea Chemical compound CC1=CC=C(CNC(N)=O)C=C1 CWQOSUOSPHUYTM-UHFFFAOYSA-N 0.000 description 1
- IDYVIOQTBVOSGC-UHFFFAOYSA-N (5-hydroxynaphthalen-2-yl)urea Chemical compound OC1=CC=CC2=CC(NC(=O)N)=CC=C21 IDYVIOQTBVOSGC-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- SDDRAJDYGWWUQJ-DHIUTWEWSA-N 1-(2-chlorophenyl)-3-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]urea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC=2C(=CC=CC=2)Cl)CC1 SDDRAJDYGWWUQJ-DHIUTWEWSA-N 0.000 description 1
- NRASAXBBBWAYRS-JWQCQUIFSA-N 1-(3-acetylphenyl)-3-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]urea Chemical compound CC(=O)C1=CC=CC(NC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 NRASAXBBBWAYRS-JWQCQUIFSA-N 0.000 description 1
- UODPPIMKJIEQBO-DHIUTWEWSA-N 1-(3-bromophenyl)-3-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]urea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC=2C=C(Br)C=CC=2)CC1 UODPPIMKJIEQBO-DHIUTWEWSA-N 0.000 description 1
- WCPPCJDQXLEBRL-DHIUTWEWSA-N 1-(3-chlorophenyl)-3-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]urea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC=2C=C(Cl)C=CC=2)CC1 WCPPCJDQXLEBRL-DHIUTWEWSA-N 0.000 description 1
- FJAXFOSQCLLXOF-UHFFFAOYSA-N 1-(3-chlorophenyl)-3-[2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]thiourea Chemical compound C1=CC(Cl)=CC=C1CC1CCN(C2C(CCC2)NC(=S)NC=2C=C(Cl)C=CC=2)CC1 FJAXFOSQCLLXOF-UHFFFAOYSA-N 0.000 description 1
- NRZPDUGSUHRLDP-JWQCQUIFSA-N 1-(4-acetylphenyl)-3-[(1R,2R)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]urea Chemical compound C(C)(=O)C1=CC=C(C=C1)NC(=O)N[C@H]1[C@@H](CCC1)N1CCC(CC1)CC1=CC=C(C=C1)Cl NRZPDUGSUHRLDP-JWQCQUIFSA-N 0.000 description 1
- SSJKWNCOPJTYRI-DHIUTWEWSA-N 1-(4-chlorophenyl)-3-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]urea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC=2C=CC(Cl)=CC=2)CC1 SSJKWNCOPJTYRI-DHIUTWEWSA-N 0.000 description 1
- BRZXLXYBGXYTSS-KAYWLYCHSA-N 1-[(1R,2R)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-naphthalen-1-ylurea Chemical compound Clc1ccc(CC2CCN(CC2)[C@@H]2CCC[C@H]2NC(=O)Nc2cccc3ccccc23)cc1 BRZXLXYBGXYTSS-KAYWLYCHSA-N 0.000 description 1
- MPGCUHLWVAEKOY-DNQXCXABSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclohexyl]-3-(3,4,5-trimethoxyphenyl)urea Chemical compound COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](CCCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 MPGCUHLWVAEKOY-DNQXCXABSA-N 0.000 description 1
- BVRLAMAYNDAXGC-JIMLSGQQSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclohexyl]-3-(3-methylsulfonylphenyl)urea;hydrochloride Chemical compound Cl.CS(=O)(=O)C1=CC=CC(NC(=O)N[C@H]2[C@@H](CCCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 BVRLAMAYNDAXGC-JIMLSGQQSA-N 0.000 description 1
- XNRCGJDOYCCXIR-FYYLOGMGSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(2,3,4-trimethoxyphenyl)urea Chemical compound COC1=C(OC)C(OC)=CC=C1NC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 XNRCGJDOYCCXIR-FYYLOGMGSA-N 0.000 description 1
- WBQBZOQDRWBOSI-IFMALSPDSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(2,3-dichlorophenyl)urea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC=2C(=C(Cl)C=CC=2)Cl)CC1 WBQBZOQDRWBOSI-IFMALSPDSA-N 0.000 description 1
- XODIPRBBJHKWHJ-DHIUTWEWSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(2,4-dichlorophenyl)urea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC=2C(=CC(Cl)=CC=2)Cl)CC1 XODIPRBBJHKWHJ-DHIUTWEWSA-N 0.000 description 1
- XLHQTKHYSVTNFS-DHIUTWEWSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(2,4-difluorophenyl)urea Chemical compound FC1=CC(F)=CC=C1NC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 XLHQTKHYSVTNFS-DHIUTWEWSA-N 0.000 description 1
- MKSFDXXMXIKIFJ-FYYLOGMGSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(2-methoxyphenyl)urea Chemical compound COC1=CC=CC=C1NC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 MKSFDXXMXIKIFJ-FYYLOGMGSA-N 0.000 description 1
- ONVHEGGZAHPQPZ-DNQXCXABSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(2-methylphenyl)thiourea Chemical compound CC1=CC=CC=C1NC(=S)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 ONVHEGGZAHPQPZ-DNQXCXABSA-N 0.000 description 1
- QAPDFULKEIAROI-DNQXCXABSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(2-methylphenyl)urea Chemical compound CC1=CC=CC=C1NC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 QAPDFULKEIAROI-DNQXCXABSA-N 0.000 description 1
- TVPKHYCTJWLQFH-IFMALSPDSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(2-nitrophenyl)urea Chemical compound [O-][N+](=O)C1=CC=CC=C1NC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 TVPKHYCTJWLQFH-IFMALSPDSA-N 0.000 description 1
- QBAWEUXTUALQLD-JWQCQUIFSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(2-phenylethyl)urea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NCCC=2C=CC=CC=2)CC1 QBAWEUXTUALQLD-JWQCQUIFSA-N 0.000 description 1
- XPJRBNKCIXSAIR-DHIUTWEWSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3,4,5-trimethoxyphenyl)urea Chemical compound COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 XPJRBNKCIXSAIR-DHIUTWEWSA-N 0.000 description 1
- WMCNQKQLHAFOKB-OHIDFYLOSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3,4,5-trimethoxyphenyl)urea;hydrochloride Chemical compound Cl.COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 WMCNQKQLHAFOKB-OHIDFYLOSA-N 0.000 description 1
- IDAYXZMIYMEASO-DHIUTWEWSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3,4-dichlorophenyl)urea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC=2C=C(Cl)C(Cl)=CC=2)CC1 IDAYXZMIYMEASO-DHIUTWEWSA-N 0.000 description 1
- CUMXHIMUHBKQRM-DHIUTWEWSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3,5-dichlorophenyl)urea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC=2C=C(Cl)C=C(Cl)C=2)CC1 CUMXHIMUHBKQRM-DHIUTWEWSA-N 0.000 description 1
- MUDMXSBSJXRWIL-JWQCQUIFSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3,5-dimethoxyphenyl)urea Chemical compound COC1=CC(OC)=CC(NC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 MUDMXSBSJXRWIL-JWQCQUIFSA-N 0.000 description 1
- PXTVCZYIHZSLBB-JWQCQUIFSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3-ethoxyphenyl)urea Chemical compound CCOC1=CC=CC(NC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 PXTVCZYIHZSLBB-JWQCQUIFSA-N 0.000 description 1
- QGQDXYDBJGFSGK-DHIUTWEWSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3-fluorophenyl)urea Chemical compound FC1=CC=CC(NC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 QGQDXYDBJGFSGK-DHIUTWEWSA-N 0.000 description 1
- MLMXXGUPAOKIFF-DNQXCXABSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3-methoxyphenyl)urea Chemical compound COC1=CC=CC(NC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 MLMXXGUPAOKIFF-DNQXCXABSA-N 0.000 description 1
- YWECYZGRIKJKJQ-DNQXCXABSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3-methylphenyl)thiourea Chemical compound CC1=CC=CC(NC(=S)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 YWECYZGRIKJKJQ-DNQXCXABSA-N 0.000 description 1
- YBMOQDSPHSVUKY-DNQXCXABSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3-methylphenyl)urea Chemical compound CC1=CC=CC(NC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 YBMOQDSPHSVUKY-DNQXCXABSA-N 0.000 description 1
- MGPXTTJIHCLSTO-DNQXCXABSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3-methylsulfonylphenyl)urea Chemical compound CS(=O)(=O)C1=CC=CC(NC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 MGPXTTJIHCLSTO-DNQXCXABSA-N 0.000 description 1
- BBKDFVKNZONAPS-DHIUTWEWSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3-nitrophenyl)urea Chemical compound [O-][N+](=O)C1=CC=CC(NC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 BBKDFVKNZONAPS-DHIUTWEWSA-N 0.000 description 1
- AQRDMBUMVXTAIZ-DHIUTWEWSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(4-fluorophenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 AQRDMBUMVXTAIZ-DHIUTWEWSA-N 0.000 description 1
- XLHSHSDASDCFDG-DHIUTWEWSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(4-iodophenyl)urea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC=2C=CC(I)=CC=2)CC1 XLHSHSDASDCFDG-DHIUTWEWSA-N 0.000 description 1
- WQIMJRWQYAICTE-KAYWLYCHSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(4-methoxynaphthalen-2-yl)urea Chemical compound C1CN([C@@H]2CCC[C@H]2NC(=O)NC=2C=C(C3=CC=CC=C3C=2)OC)CCC1CC1=CC=C(Cl)C=C1 WQIMJRWQYAICTE-KAYWLYCHSA-N 0.000 description 1
- XIBXEONUKFASPY-DNQXCXABSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(4-methoxyphenyl)thiourea Chemical compound C1=CC(OC)=CC=C1NC(=S)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 XIBXEONUKFASPY-DNQXCXABSA-N 0.000 description 1
- UTBDKKKWPMPFAD-DNQXCXABSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(4-methylphenyl)thiourea Chemical compound C1=CC(C)=CC=C1NC(=S)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 UTBDKKKWPMPFAD-DNQXCXABSA-N 0.000 description 1
- CDHWPDTWBXZDQJ-DNQXCXABSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(4-methylphenyl)urea Chemical compound C1=CC(C)=CC=C1NC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 CDHWPDTWBXZDQJ-DNQXCXABSA-N 0.000 description 1
- XDEFRCFAUYNXFS-CLJLJLNGSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(4-propan-2-ylphenyl)urea Chemical compound C1=CC(C(C)C)=CC=C1NC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 XDEFRCFAUYNXFS-CLJLJLNGSA-N 0.000 description 1
- VBGXKAWILWDTJK-DHIUTWEWSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(8-hydroxyquinolin-2-yl)urea Chemical compound C1CN([C@@H]2CCC[C@H]2NC(=O)NC2=CC=C3C=CC=C(C3=N2)O)CCC1CC1=CC=C(Cl)C=C1 VBGXKAWILWDTJK-DHIUTWEWSA-N 0.000 description 1
- CYJXRSSOKRBQLP-JIMLSGQQSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-[2-(3,4,5-trimethoxyphenyl)ethyl]urea;hydrochloride Chemical compound Cl.COC1=C(OC)C(OC)=CC(CCNC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 CYJXRSSOKRBQLP-JIMLSGQQSA-N 0.000 description 1
- MSKQBFPWFFEXSL-DNQXCXABSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-[3-(methylamino)phenyl]urea Chemical compound CNC1=CC=CC(NC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 MSKQBFPWFFEXSL-DNQXCXABSA-N 0.000 description 1
- YGKMWYJGUXIMLU-DHIUTWEWSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-[4-(trifluoromethyl)phenyl]urea Chemical compound C1=CC(C(F)(F)F)=CC=C1NC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 YGKMWYJGUXIMLU-DHIUTWEWSA-N 0.000 description 1
- NGJFTTUFSAZOMS-DHIUTWEWSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-cyclohexylurea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC2CCCCC2)CC1 NGJFTTUFSAZOMS-DHIUTWEWSA-N 0.000 description 1
- UHPHFARKDWMDOH-KAYWLYCHSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-naphthalen-2-ylurea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC=2C=C3C=CC=CC3=CC=2)CC1 UHPHFARKDWMDOH-KAYWLYCHSA-N 0.000 description 1
- JKEDHPYYVUPHPW-CLJLJLNGSA-N 1-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-quinolin-6-ylurea Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)NC=2C=C3C=CC=NC3=CC=2)CC1 JKEDHPYYVUPHPW-CLJLJLNGSA-N 0.000 description 1
- XZQKOSUQUPUVEC-YXOGGFTGSA-N 1-[(1r,2r,4s)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]-4-(hydroxymethyl)cyclopentyl]-3-(3,4,5-trimethoxyphenyl)urea;hydrochloride Chemical compound Cl.COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](C[C@@H](CO)C2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 XZQKOSUQUPUVEC-YXOGGFTGSA-N 0.000 description 1
- UYRMTSNBBKIJPC-FTBPSBKWSA-N 1-[(1r,2r,4s)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]-4-(methoxymethyl)cyclopentyl]-3-(3,4,5-trimethoxyphenyl)urea Chemical compound N([C@@H]1C[C@@H](C[C@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1)COC)C(=O)NC1=CC(OC)=C(OC)C(OC)=C1 UYRMTSNBBKIJPC-FTBPSBKWSA-N 0.000 description 1
- FOIMZALURCNXLY-DRRWBVTNSA-N 1-[(1r,2r,4s)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]-4-(methoxymethyl)cyclopentyl]-3-(3,4,5-trimethoxyphenyl)urea;hydrochloride Chemical compound Cl.N([C@@H]1C[C@@H](C[C@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1)COC)C(=O)NC1=CC(OC)=C(OC)C(OC)=C1 FOIMZALURCNXLY-DRRWBVTNSA-N 0.000 description 1
- FSSQVRNRYVMCDW-SLQRLHQASA-N 1-[(1r,2r,4s)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]-4-hydroxycyclopentyl]-3-(3,4,5-trimethoxyphenyl)urea;hydrochloride Chemical compound Cl.COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](C[C@@H](O)C2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 FSSQVRNRYVMCDW-SLQRLHQASA-N 0.000 description 1
- LHLARPAVYPYCGR-UPRLRBBYSA-N 1-[(1r,2r,4s)-4-[tert-butyl(dimethyl)silyl]oxy-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3-(3,4,5-trimethoxyphenyl)urea Chemical compound COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](C[C@H](C2)O[Si](C)(C)C(C)(C)C)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 LHLARPAVYPYCGR-UPRLRBBYSA-N 0.000 description 1
- VGYLUYBQFNZKKF-NSLUPJTDSA-N 1-[(1r,2s)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclobutyl]-3-(3,4,5-trimethoxyphenyl)urea;hydrochloride Chemical compound Cl.COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@H](CC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 VGYLUYBQFNZKKF-NSLUPJTDSA-N 0.000 description 1
- AJIISAARSGPFQN-DLBZAZTESA-N 1-[(1r,2s)-2-azidocyclopentyl]-4-[(4-chlorophenyl)methyl]piperidine Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@H](CCC2)N=[N+]=[N-])CC1 AJIISAARSGPFQN-DLBZAZTESA-N 0.000 description 1
- SFZFQSHGFBQYJO-XZHZQXPNSA-N 1-[(3R,4R)-4-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]pyrrolidin-3-yl]-3-(3,4,5-trimethoxyphenyl)urea dihydrochloride Chemical compound Cl.Cl.COc1cc(NC(=O)N[C@@H]2CNC[C@H]2N2CCC(Cc3ccc(Cl)cc3)CC2)cc(OC)c1OC SFZFQSHGFBQYJO-XZHZQXPNSA-N 0.000 description 1
- SKAOLAHDUOSDDF-FGZHOGPDSA-N 1-[(3s,4s)-4-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]oxolan-3-yl]-3-(3,4,5-trimethoxyphenyl)urea Chemical compound COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](COC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 SKAOLAHDUOSDDF-FGZHOGPDSA-N 0.000 description 1
- WUIJTQZXUURFQU-UHFFFAOYSA-N 1-methylsulfonylethene Chemical compound CS(=O)(=O)C=C WUIJTQZXUURFQU-UHFFFAOYSA-N 0.000 description 1
- SPXOTSHWBDUUMT-UHFFFAOYSA-N 138-42-1 Chemical compound OS(=O)(=O)C1=CC=C([N+]([O-])=O)C=C1 SPXOTSHWBDUUMT-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- PTHLPYKPCQLAOF-UHFFFAOYSA-N 2,4-difluorobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(F)C=C1F PTHLPYKPCQLAOF-UHFFFAOYSA-N 0.000 description 1
- KJMYEQUQHKISSS-UHFFFAOYSA-N 2-(3,4,5-trimethoxyphenyl)acetamide Chemical compound COC1=CC(CC(N)=O)=CC(OC)=C1OC KJMYEQUQHKISSS-UHFFFAOYSA-N 0.000 description 1
- IGQLVMZOXABYCF-DNQXCXABSA-N 2-(3-bromophenyl)-n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]acetamide Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)CC=2C=C(Br)C=CC=2)CC1 IGQLVMZOXABYCF-DNQXCXABSA-N 0.000 description 1
- FBSIKJFOVXUNMI-UHFFFAOYSA-N 2-(3-chlorophenyl)acetamide Chemical compound NC(=O)CC1=CC=CC(Cl)=C1 FBSIKJFOVXUNMI-UHFFFAOYSA-N 0.000 description 1
- LFXZYCRMLYASOK-DNQXCXABSA-N 2-(4-chlorophenyl)-n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]acetamide Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)CC=2C=CC(Cl)=CC=2)CC1 LFXZYCRMLYASOK-DNQXCXABSA-N 0.000 description 1
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical class O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 1
- QBAYIBZITZBSFO-UHFFFAOYSA-N 2-(trifluoromethyl)benzamide Chemical compound NC(=O)C1=CC=CC=C1C(F)(F)F QBAYIBZITZBSFO-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- STEPGCUAPJTXTM-UHFFFAOYSA-N 2-[5-(3,4-dimethoxyphenyl)pyrimidin-2-yl]sulfanylacetamide hydrochloride Chemical compound COC1=C(C=C(C=C1)C2=CN=C(N=C2)SCC(=O)N)OC.Cl STEPGCUAPJTXTM-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 1
- UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical group C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 1
- MNWSGMTUGXNYHJ-UHFFFAOYSA-N 2-methoxybenzamide Chemical compound COC1=CC=CC=C1C(N)=O MNWSGMTUGXNYHJ-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- KRTGJZMJJVEKRX-UHFFFAOYSA-N 2-phenylethan-1-yl Chemical group [CH2]CC1=CC=CC=C1 KRTGJZMJJVEKRX-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- OPFZOWWTCYPZND-UHFFFAOYSA-N 2-thiophen-2-ylethylurea Chemical compound NC(=O)NCCC1=CC=CS1 OPFZOWWTCYPZND-UHFFFAOYSA-N 0.000 description 1
- MEZNPUULYGXXFL-UHFFFAOYSA-N 3,4-dimethoxybenzenesulfonamide Chemical compound COC1=CC=C(S(N)(=O)=O)C=C1OC MEZNPUULYGXXFL-UHFFFAOYSA-N 0.000 description 1
- YNOPIKHMZIOWHS-UHFFFAOYSA-N 3,5-bis(trifluoromethyl)benzamide Chemical compound NC(=O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 YNOPIKHMZIOWHS-UHFFFAOYSA-N 0.000 description 1
- AIUTZIYTEUMXGG-UHFFFAOYSA-N 3,6-dioxabicyclo[3.1.0]hexane Chemical compound C1OCC2OC12 AIUTZIYTEUMXGG-UHFFFAOYSA-N 0.000 description 1
- XLZYKTYMLBOINK-UHFFFAOYSA-N 3-(4-hydroxybenzoyl)benzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)C=2C=CC(O)=CC=2)=C1 XLZYKTYMLBOINK-UHFFFAOYSA-N 0.000 description 1
- XBGXGCOLWCMVOI-UHFFFAOYSA-N 3-(trifluoromethyl)benzamide Chemical compound NC(=O)C1=CC=CC(C(F)(F)F)=C1 XBGXGCOLWCMVOI-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 1
- VKPLPDIMEREJJF-UHFFFAOYSA-N 3-methoxybenzamide Chemical compound COC1=CC=CC(C(N)=O)=C1 VKPLPDIMEREJJF-UHFFFAOYSA-N 0.000 description 1
- WGRPQCFFBRDZFV-UHFFFAOYSA-N 3-methylbenzamide Chemical compound CC1=CC=CC(C(N)=O)=C1 WGRPQCFFBRDZFV-UHFFFAOYSA-N 0.000 description 1
- MBNPJRQKQLLRIS-UHFFFAOYSA-N 3-methylsulfonylaniline Chemical compound CS(=O)(=O)C1=CC=CC(N)=C1 MBNPJRQKQLLRIS-UHFFFAOYSA-N 0.000 description 1
- KWAYEPXDGHYGRW-UHFFFAOYSA-N 3-nitrobenzamide Chemical compound NC(=O)C1=CC=CC([N+]([O-])=O)=C1 KWAYEPXDGHYGRW-UHFFFAOYSA-N 0.000 description 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- WEJHBEDHLLBJFW-UHFFFAOYSA-N 4-(trifluoromethyl)benzamide Chemical compound NC(=O)C1=CC=C(C(F)(F)F)C=C1 WEJHBEDHLLBJFW-UHFFFAOYSA-N 0.000 description 1
- RJWBTWIBUIGANW-UHFFFAOYSA-N 4-chlorobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Cl)C=C1 RJWBTWIBUIGANW-UHFFFAOYSA-N 0.000 description 1
- AZEIRPAUJXANCS-UHFFFAOYSA-N 4-ethoxybenzamide Chemical compound CCOC1=CC=C(C(N)=O)C=C1 AZEIRPAUJXANCS-UHFFFAOYSA-N 0.000 description 1
- MLTGAVXHWSDGIS-UHFFFAOYSA-N 4-ethylbenzenesulfonamide Chemical compound CCC1=CC=C(S(N)(=O)=O)C=C1 MLTGAVXHWSDGIS-UHFFFAOYSA-N 0.000 description 1
- LFLSATHZMYYIAQ-UHFFFAOYSA-N 4-flourobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(F)C=C1 LFLSATHZMYYIAQ-UHFFFAOYSA-N 0.000 description 1
- VNDHYTGVCGVETQ-UHFFFAOYSA-N 4-fluorobenzamide Chemical compound NC(=O)C1=CC=C(F)C=C1 VNDHYTGVCGVETQ-UHFFFAOYSA-N 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- SFKZPTYRENGBTJ-UHFFFAOYSA-N 4-methoxynaphthalen-2-amine Chemical compound C1=CC=C2C(OC)=CC(N)=CC2=C1 SFKZPTYRENGBTJ-UHFFFAOYSA-N 0.000 description 1
- HTJWEYNKKDOMOB-UHFFFAOYSA-N 4-methylsulfonylbenzamide;hydrochloride Chemical compound Cl.CS(=O)(=O)C1=CC=C(C(N)=O)C=C1 HTJWEYNKKDOMOB-UHFFFAOYSA-N 0.000 description 1
- OXLLOGLZHQOVJQ-UHFFFAOYSA-N 4-methylsulfonylbenzenesulfonamide Chemical compound CS(=O)(=O)C1=CC=C(S(N)(=O)=O)C=C1 OXLLOGLZHQOVJQ-UHFFFAOYSA-N 0.000 description 1
- ZESWUEBPRPGMTP-UHFFFAOYSA-N 4-nitrobenzamide Chemical compound NC(=O)C1=CC=C([N+]([O-])=O)C=C1 ZESWUEBPRPGMTP-UHFFFAOYSA-N 0.000 description 1
- CGLLDGRBWCZOGT-ILBGXUMGSA-N 5-chloro-n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-1h-indole-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)C=2NC3=CC=C(Cl)C=C3C=2)CC1 CGLLDGRBWCZOGT-ILBGXUMGSA-N 0.000 description 1
- GJEZBVHHZQAEDB-UHFFFAOYSA-N 6-oxabicyclo[3.1.0]hexane Chemical compound C1CCC2OC21 GJEZBVHHZQAEDB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 102100034871 C-C motif chemokine 8 Human genes 0.000 description 1
- 101710155833 C-C motif chemokine 8 Proteins 0.000 description 1
- OPEOVZGFOVKAMW-BNUOYOMZSA-N CC(=O)N1C[C@H]([C@@H](C1)N2CCC(CC2)CC3=CC=C(C=C3)Cl)NC(=O)NC4=CC(=C(C(=C4)OC)OC)OC.Cl Chemical compound CC(=O)N1C[C@H]([C@@H](C1)N2CCC(CC2)CC3=CC=C(C=C3)Cl)NC(=O)NC4=CC(=C(C(=C4)OC)OC)OC.Cl OPEOVZGFOVKAMW-BNUOYOMZSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- VKPRMTZLQXANFO-OHIDFYLOSA-N COC1=CC(=CC(=C1OC)OC)NC(=O)N[C@@H]2CN(C[C@H]2N3CCC(CC3)CC4=CC=C(C=C4)Cl)S(=O)(=O)C.Cl Chemical compound COC1=CC(=CC(=C1OC)OC)NC(=O)N[C@@H]2CN(C[C@H]2N3CCC(CC3)CC4=CC=C(C=C4)Cl)S(=O)(=O)C.Cl VKPRMTZLQXANFO-OHIDFYLOSA-N 0.000 description 1
- OYVAEXVQHXQEEH-HLUKFBSCSA-N COC1=CC(=CC(=C1OC)OC)NC(=O)N[C@@H]2COC[C@H]2N3CCC(CC3)CC4=CC=C(C=C4)Cl.Cl Chemical compound COC1=CC(=CC(=C1OC)OC)NC(=O)N[C@@H]2COC[C@H]2N3CCC(CC3)CC4=CC=C(C=C4)Cl.Cl OYVAEXVQHXQEEH-HLUKFBSCSA-N 0.000 description 1
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 102000009410 Chemokine receptor Human genes 0.000 description 1
- 108050000299 Chemokine receptor Proteins 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FAKQBTKHZSIPNT-HLUKFBSCSA-N Cl.COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](CN(C2)C(N)=O)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 Chemical compound Cl.COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](CN(C2)C(N)=O)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 FAKQBTKHZSIPNT-HLUKFBSCSA-N 0.000 description 1
- HTKPLUMMZPOEIN-HLUKFBSCSA-N Cl.COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](CN(C2)S(N)(=O)=O)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 Chemical compound Cl.COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](CN(C2)S(N)(=O)=O)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 HTKPLUMMZPOEIN-HLUKFBSCSA-N 0.000 description 1
- JARSDGHJHKMWTM-LBDKHHEASA-N Cl.Cl.ClC1=CC=C(CC2CCN(CC2)[C@H]2[C@@H](CN(C2)CCS(=O)(=O)C)NC(=O)NC2=CC(=C(C(=C2)OC)OC)OC)C=C1 Chemical compound Cl.Cl.ClC1=CC=C(CC2CCN(CC2)[C@H]2[C@@H](CN(C2)CCS(=O)(=O)C)NC(=O)NC2=CC(=C(C(=C2)OC)OC)OC)C=C1 JARSDGHJHKMWTM-LBDKHHEASA-N 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Chemical group OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012435 Dermatitis and eczema Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 1
- 206010014950 Eosinophilia Diseases 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Chemical group OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 101000978392 Homo sapiens Eotaxin Proteins 0.000 description 1
- 208000016300 Idiopathic chronic eosinophilic pneumonia Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 102000000646 Interleukin-3 Human genes 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 108010002616 Interleukin-5 Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Chemical group OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- YRBQBDGDLDQEAJ-UHFFFAOYSA-N N,N-dimethyl-3-[(3,4,5-trimethoxyphenyl)carbamoylamino]pyrrolidine-1-carboxamide hydrochloride Chemical compound CN(C)C(=O)N1CCC(C1)NC(=O)NC2=CC(=C(C(=C2)OC)OC)OC.Cl YRBQBDGDLDQEAJ-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 229910020889 NaBH3 Inorganic materials 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229910003849 O-Si Inorganic materials 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910003872 O—Si Inorganic materials 0.000 description 1
- 102100032341 PCNA-interacting partner Human genes 0.000 description 1
- 101710196737 PCNA-interacting partner Proteins 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920005372 Plexiglas® Polymers 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000555028 Sternidius alpha Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- AEFSVCMAQJIBMG-GHMZBOCLSA-N [(1r,2r)-2-azidocyclopentyl] 4-nitrobenzenesulfonate Chemical compound C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)O[C@H]1[C@H](N=[N+]=[N-])CCC1 AEFSVCMAQJIBMG-GHMZBOCLSA-N 0.000 description 1
- VYWQTJWGWLKBQA-UHFFFAOYSA-N [amino(hydroxy)methylidene]azanium;chloride Chemical compound Cl.NC(N)=O VYWQTJWGWLKBQA-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 125000005354 acylalkyl group Chemical group 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 125000005199 aryl carbonyloxy group Chemical group 0.000 description 1
- 125000000732 arylene group Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940054066 benzamide antipsychotics Drugs 0.000 description 1
- 150000003936 benzamides Chemical class 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- DIYSQJWFPSHXJT-DNQXCXABSA-N benzyl n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]carbamate Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)OCC=2C=CC=CC=2)CC1 DIYSQJWFPSHXJT-DNQXCXABSA-N 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000004799 bromophenyl group Chemical group 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 201000009323 chronic eosinophilic pneumonia Diseases 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 125000004966 cyanoalkyl group Chemical group 0.000 description 1
- 125000004802 cyanophenyl group Chemical group 0.000 description 1
- 108010011222 cyclo(Arg-Pro) Proteins 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- ZWAJLVLEBYIOTI-UHFFFAOYSA-N cyclohexene oxide Chemical compound C1CCCC2OC21 ZWAJLVLEBYIOTI-UHFFFAOYSA-N 0.000 description 1
- 125000006639 cyclohexyl carbonyl group Chemical group 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical group CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000013764 eosinophil chemotaxis Effects 0.000 description 1
- 230000002327 eosinophilic effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 201000001155 extrinsic allergic alveolitis Diseases 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Chemical group 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004220 glutamic acid Chemical group 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 1
- 125000005549 heteroarylene group Chemical group 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000004047 hyperresponsiveness Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 208000022098 hypersensitivity pneumonitis Diseases 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- RIIUDOCVFNYSEM-UHFFFAOYSA-N isoquinolin-3-ylurea Chemical compound C1=CC=C2C=NC(NC(=O)N)=CC2=C1 RIIUDOCVFNYSEM-UHFFFAOYSA-N 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- JFCHSQDLLFJHOA-UHFFFAOYSA-N n,n-dimethylsulfamoyl chloride Chemical compound CN(C)S(Cl)(=O)=O JFCHSQDLLFJHOA-UHFFFAOYSA-N 0.000 description 1
- JYTZEBKTUUJYPN-OHIDFYLOSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclobutyl]-4-methylsulfonylbenzamide;hydrochloride Chemical compound Cl.C1=CC(S(=O)(=O)C)=CC=C1C(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CC1 JYTZEBKTUUJYPN-OHIDFYLOSA-N 0.000 description 1
- LJJAUAKOLGKZIA-JWQCQUIFSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclohexyl]-4-methylsulfonylbenzamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCCC1 LJJAUAKOLGKZIA-JWQCQUIFSA-N 0.000 description 1
- AHYLULZKNKPXAK-DHIUTWEWSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-2,5-dimethoxybenzenesulfonamide Chemical compound COC1=CC=C(OC)C(S(=O)(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 AHYLULZKNKPXAK-DHIUTWEWSA-N 0.000 description 1
- NDSZQRRDIBASRF-JWQCQUIFSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-2-(2-methylphenyl)acetamide Chemical compound CC1=CC=CC=C1CC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 NDSZQRRDIBASRF-JWQCQUIFSA-N 0.000 description 1
- ZCWMMSNRHRPESC-JWQCQUIFSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-2-(3-methoxyphenyl)acetamide Chemical compound COC1=CC=CC(CC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 ZCWMMSNRHRPESC-JWQCQUIFSA-N 0.000 description 1
- KXIYZFBRFIIMJQ-DNQXCXABSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-2-(4-fluorophenyl)acetamide Chemical compound C1=CC(F)=CC=C1CC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 KXIYZFBRFIIMJQ-DNQXCXABSA-N 0.000 description 1
- ZMORKSOLOLSVLJ-JWQCQUIFSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-2-(4-methoxyphenyl)acetamide Chemical compound C1=CC(OC)=CC=C1CC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 ZMORKSOLOLSVLJ-JWQCQUIFSA-N 0.000 description 1
- KDHBGGBIFBOYFW-KAYWLYCHSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-2-[5-(3,4-dimethoxyphenyl)pyrimidin-2-yl]sulfanylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1C(C=N1)=CN=C1SCC(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 KDHBGGBIFBOYFW-KAYWLYCHSA-N 0.000 description 1
- HMFKUTJNGODWKO-DHIUTWEWSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 HMFKUTJNGODWKO-DHIUTWEWSA-N 0.000 description 1
- SGIREIHWBBJITL-FGZHOGPDSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-2-fluorobenzenesulfonamide Chemical compound FC1=CC=CC=C1S(=O)(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 SGIREIHWBBJITL-FGZHOGPDSA-N 0.000 description 1
- BZJAXOTYAOJKPV-NHCUHLMSSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-2-nitro-4-(trifluoromethyl)benzenesulfonamide Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 BZJAXOTYAOJKPV-NHCUHLMSSA-N 0.000 description 1
- IUNQQSCSCHIONS-NHCUHLMSSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-2-nitrobenzenesulfonamide Chemical compound [O-][N+](=O)C1=CC=CC=C1S(=O)(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 IUNQQSCSCHIONS-NHCUHLMSSA-N 0.000 description 1
- AQVIHHFWKURPCK-JWQCQUIFSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-3,5-dimethoxybenzamide Chemical compound COC1=CC(OC)=CC(C(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 AQVIHHFWKURPCK-JWQCQUIFSA-N 0.000 description 1
- TUANNBJZQZOOCZ-DNQXCXABSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-4-cyanobenzamide Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)C=2C=CC(=CC=2)C#N)CC1 TUANNBJZQZOOCZ-DNQXCXABSA-N 0.000 description 1
- LZONIGRBDIDAOG-DHIUTWEWSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-4-iodobenzamide Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)C=2C=CC(I)=CC=2)CC1 LZONIGRBDIDAOG-DHIUTWEWSA-N 0.000 description 1
- BMDRUFCQIYZGFT-DNQXCXABSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-4-methoxybenzamide Chemical compound C1=CC(OC)=CC=C1C(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 BMDRUFCQIYZGFT-DNQXCXABSA-N 0.000 description 1
- YRTSWSAXIBANIT-DNQXCXABSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-4-methylbenzenesulfonamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 YRTSWSAXIBANIT-DNQXCXABSA-N 0.000 description 1
- RCSLEAJNGKSJJA-DNQXCXABSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-4-methylsulfonylbenzamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 RCSLEAJNGKSJJA-DNQXCXABSA-N 0.000 description 1
- FBDABIRDUXWHSL-DHIUTWEWSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-4-nitrobenzenesulfonamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 FBDABIRDUXWHSL-DHIUTWEWSA-N 0.000 description 1
- WCSJFMAWPLOWEP-CLJLJLNGSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-4-propan-2-ylbenzamide Chemical compound C1=CC(C(C)C)=CC=C1C(=O)N[C@H]1[C@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCC1 WCSJFMAWPLOWEP-CLJLJLNGSA-N 0.000 description 1
- VSTRRZNDAJAQDD-ILBGXUMGSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-5-fluoro-1h-indole-2-carboxamide Chemical compound C1CN([C@@H]2CCC[C@H]2NC(=O)C=2NC3=CC=C(C=C3C=2)F)CCC1CC1=CC=C(Cl)C=C1 VSTRRZNDAJAQDD-ILBGXUMGSA-N 0.000 description 1
- FRAQVULFZWINON-AOYPEHQESA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-5-methoxy-1h-indole-2-carboxamide Chemical compound C1CN([C@@H]2CCC[C@H]2NC(=O)C=2NC3=CC=C(C=C3C=2)OC)CCC1CC1=CC=C(Cl)C=C1 FRAQVULFZWINON-AOYPEHQESA-N 0.000 description 1
- GVNQALLXWZUYNO-AOYPEHQESA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]-5-methyl-1h-indole-2-carboxamide Chemical compound C1CN([C@@H]2CCC[C@H]2NC(=O)C=2NC3=CC=C(C=C3C=2)C)CCC1CC1=CC=C(Cl)C=C1 GVNQALLXWZUYNO-AOYPEHQESA-N 0.000 description 1
- ZXVVPTXQXSPJLU-DHIUTWEWSA-N n-[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]benzamide Chemical compound C1=CC(Cl)=CC=C1CC1CCN([C@H]2[C@@H](CCC2)NC(=O)C=2C=CC=CC=2)CC1 ZXVVPTXQXSPJLU-DHIUTWEWSA-N 0.000 description 1
- VXBCDQKAJUFSTD-CNORLSDQSA-N n-[(1r,2s)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclohexyl]-2-[5-(3,4-dimethoxyphenyl)pyrimidin-2-yl]sulfanylacetamide;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1C(C=N1)=CN=C1SCC(=O)N[C@H]1[C@@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCCC1 VXBCDQKAJUFSTD-CNORLSDQSA-N 0.000 description 1
- YRAXTEYDNVNBSN-KGQXAQPSSA-N n-[(1r,2s)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclohexyl]-4-methylsulfonylbenzamide;hydrochloride Chemical compound Cl.C1=CC(S(=O)(=O)C)=CC=C1C(=O)N[C@H]1[C@@H](N2CCC(CC=3C=CC(Cl)=CC=3)CC2)CCCC1 YRAXTEYDNVNBSN-KGQXAQPSSA-N 0.000 description 1
- CZCKOFDDKDANKX-JWQCQUIFSA-N n-[3-[[(1r,2r)-2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]cyclopentyl]carbamoylamino]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(NC(=O)N[C@H]2[C@@H](CCC2)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 CZCKOFDDKDANKX-JWQCQUIFSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Chemical group OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 201000009732 pulmonary eosinophilia Diseases 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- ZVCDLGYNFYZZOK-UHFFFAOYSA-M sodium cyanate Chemical compound [Na]OC#N ZVCDLGYNFYZZOK-UHFFFAOYSA-M 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Chemical group 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- ZIGZZMVEUYFWRC-JWQCQUIFSA-N tert-butyl (3r,4r)-3-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]-4-[(3,4,5-trimethoxyphenyl)carbamoylamino]pyrrolidine-1-carboxylate Chemical compound COC1=C(OC)C(OC)=CC(NC(=O)N[C@H]2[C@@H](CN(C2)C(=O)OC(C)(C)C)N2CCC(CC=3C=CC(Cl)=CC=3)CC2)=C1 ZIGZZMVEUYFWRC-JWQCQUIFSA-N 0.000 description 1
- SFJZFXKAAZQWLZ-RTBURBONSA-N tert-butyl (3r,4r)-3-amino-4-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)C[C@@H](N)[C@@H]1N1CCC(CC=2C=CC(Cl)=CC=2)CC1 SFJZFXKAAZQWLZ-RTBURBONSA-N 0.000 description 1
- YULPGFXVBJPKPG-UHFFFAOYSA-N tert-butyl 4-[(4-chlorophenyl)methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CC1=CC=C(Cl)C=C1 YULPGFXVBJPKPG-UHFFFAOYSA-N 0.000 description 1
- FEXIDQDEGTVERB-UHFFFAOYSA-N tert-butyl 4-[(4-chlorophenyl)methylidene]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1=CC1=CC=C(Cl)C=C1 FEXIDQDEGTVERB-UHFFFAOYSA-N 0.000 description 1
- NXZIGGBPLGAPTI-UHFFFAOYSA-N tert-butyl 6-oxa-3-azabicyclo[3.1.0]hexane-3-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CC2OC21 NXZIGGBPLGAPTI-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005887 tetrahydrobenzofuranyl group Chemical group 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 1
- ISXOBTBCNRIIQO-UHFFFAOYSA-N tetrahydrothiophene 1-oxide Chemical compound O=S1CCCC1 ISXOBTBCNRIIQO-UHFFFAOYSA-N 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 150000003585 thioureas Chemical class 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 125000005951 trifluoromethanesulfonyloxy group Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000001680 trimethoxyphenyl group Chemical group 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33465301P | 2001-11-30 | 2001-11-30 | |
US60/334,653 | 2001-11-30 | ||
PCT/EP2002/013218 WO2003045937A1 (fr) | 2001-11-30 | 2002-11-25 | N-ureido-piperidines utilises comme antagonistes viii du recepteur ccr3 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002352123A1 true AU2002352123A1 (en) | 2003-06-10 |
Family
ID=23308166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002352123A Abandoned AU2002352123A1 (en) | 2001-11-30 | 2002-11-25 | N-ureido-piperidines as antagonists viii for ccr-3 receptor |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1453825A1 (fr) |
JP (1) | JP2005515193A (fr) |
KR (1) | KR100652450B1 (fr) |
CN (1) | CN1286831C (fr) |
AR (1) | AR037458A1 (fr) |
AU (1) | AU2002352123A1 (fr) |
BR (1) | BR0214613A (fr) |
CA (1) | CA2467874A1 (fr) |
MX (1) | MXPA04005176A (fr) |
PL (1) | PL370821A1 (fr) |
RU (1) | RU2004120064A (fr) |
WO (1) | WO2003045937A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7491737B2 (en) * | 2002-10-30 | 2009-02-17 | Merck & Co., Inc. | Heterarylpiperidine modulators of chemokine receptor activity |
IN2006CH00378A (en) * | 2003-06-30 | 2007-05-11 | Sumitomo Chemical Co | Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst |
WO2005058805A1 (fr) * | 2003-12-17 | 2005-06-30 | Sumitomo Chemical Company, Limited | Procede de production de compose amine optiquement actif |
WO2006071875A1 (fr) | 2004-12-29 | 2006-07-06 | Millennium Pharmaceuticals, Inc. | Composes utilises comme antagonistes des recepteurs de la chemokine |
US7635698B2 (en) | 2004-12-29 | 2009-12-22 | Millennium Pharmaceuticals, Inc. | Compounds useful as chemokine receptor antagonists |
EP2805985A1 (fr) * | 2013-05-22 | 2014-11-26 | Sika Technology AG | Hydroxysilane et polymère contenant des groupes silanes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1206219C (zh) * | 1998-12-18 | 2005-06-15 | 布里斯托尔-迈尔斯斯奎布药品公司 | 作为趋化因子受体活性调节剂的n-脲基烷基-哌啶化合物 |
-
2002
- 2002-11-25 WO PCT/EP2002/013218 patent/WO2003045937A1/fr active Application Filing
- 2002-11-25 MX MXPA04005176A patent/MXPA04005176A/es active IP Right Grant
- 2002-11-25 JP JP2003547387A patent/JP2005515193A/ja active Pending
- 2002-11-25 AU AU2002352123A patent/AU2002352123A1/en not_active Abandoned
- 2002-11-25 PL PL02370821A patent/PL370821A1/xx not_active Application Discontinuation
- 2002-11-25 RU RU2004120064/04A patent/RU2004120064A/ru not_active Application Discontinuation
- 2002-11-25 EP EP02787796A patent/EP1453825A1/fr not_active Withdrawn
- 2002-11-25 CA CA002467874A patent/CA2467874A1/fr not_active Abandoned
- 2002-11-25 CN CNB028239784A patent/CN1286831C/zh not_active Expired - Fee Related
- 2002-11-25 KR KR1020047008357A patent/KR100652450B1/ko not_active IP Right Cessation
- 2002-11-25 BR BR0214613-4A patent/BR0214613A/pt not_active IP Right Cessation
- 2002-11-28 AR ARP020104581A patent/AR037458A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL370821A1 (en) | 2005-05-30 |
RU2004120064A (ru) | 2006-01-10 |
CN1599733A (zh) | 2005-03-23 |
BR0214613A (pt) | 2004-09-14 |
CA2467874A1 (fr) | 2003-06-05 |
AR037458A1 (es) | 2004-11-10 |
MXPA04005176A (es) | 2004-08-11 |
KR100652450B1 (ko) | 2007-02-28 |
EP1453825A1 (fr) | 2004-09-08 |
WO2003045937A1 (fr) | 2003-06-05 |
CN1286831C (zh) | 2006-11-29 |
KR20040062665A (ko) | 2004-07-07 |
JP2005515193A (ja) | 2005-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0903349A2 (fr) | Antagonistes du récepteur CCR-3 | |
AU1045900A (en) | 4-aroyl-piperidin-ccr-3 receptor antagonists iii | |
KR100586131B1 (ko) | Ccr-3 수용체 길항제로서 천식 치료에 사용하기 위한피페라진 유도체 | |
US6770650B2 (en) | Cyclic amine derivatives-CCR-3 receptor antagonists | |
US6977265B2 (en) | Piperidine CCR-3 receptor antagonists | |
AU2002352123A1 (en) | N-ureido-piperidines as antagonists viii for ccr-3 receptor | |
KR100579352B1 (ko) | Ccr-3 수용체 길항제 ⅶ | |
US6984643B2 (en) | 2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists | |
KR100652451B1 (ko) | Ccr-3 수용체 길항제 v | |
MXPA98006690A (es) | Antagonistas del receptor ccr-3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |